PHYSIOLOGICAL MODELING OF ORGANIC-COMPOUNDS

被引:63
作者
ANDERSEN, ME
机构
[1] Chemical Industry Institute of Toxicology, Research Triangle Park NC 27709
关键词
D O I
10.1093/annhyg/35.3.309
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In pharmacokinetic modelling the body is represented as a set of compartments. The characteristics of these compartments are defined either by fitting predetermined mathematical equations to the data ('data-based compartments') or by defining compartments based on the actual biological structure of the animal ('physiologically based compartments'). Physiological models of chemical disposition are developed using these physiologically based compartments. These models then consist of sets of organs or types of tissue compartments whose characteristics are based as far as possible on the anatomy and physiology of the test species. Individual organs or types of tissue are defined with respect to their blood flow, volume, kinetic constants for metabolism, storage capacity for the compound involved, protein binding and other relevant characteristics. Linking these compartments together in a proper anatomical arrangement yields the physiological model for compound disposition. This paper provides an overview of the basics for constructing physiological models for organic compounds, focusing on the structure of individual compartments in these models and the data required for model development. Some past applications of physiological models are reviewed and speculation offered on future developments in this field.
引用
收藏
页码:309 / 321
页数:13
相关论文
共 40 条
[1]  
ANDERSEN ME, 1981, NEUROBEH TOXICOL TER, V3, P383
[2]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[3]   DETERMINATION OF THE KINETIC CONSTANTS FOR METABOLISM OF INHALED TOXICANTS INVIVO USING GAS UPTAKE MEASUREMENTS [J].
ANDERSEN, ME ;
GARGAS, ML ;
JONES, RA ;
JENKINS, LJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 54 (01) :100-116
[4]   METHOTREXATE PHARMACOKINETICS [J].
BISCHOFF, KB ;
DEDRICK, RL ;
ZAHARKO, DS ;
LONGSTRETH, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (08) :1128-+
[5]  
Clewell H J 3rd, 1985, Toxicol Ind Health, V1, P111
[6]   IMPROVING TOXICOLOGY TESTING PROTOCOLS USING COMPUTER-SIMULATIONS [J].
CLEWELL, HJ ;
ANDERSEN, ME .
TOXICOLOGY LETTERS, 1989, 49 (2-3) :139-158
[7]  
DSOUZA RW, 1988, J PHARMACOL EXP THER, V245, P563
[8]   INHALATION PHARMACOKINETICS BASED ON GAS UPTAKE STUDIES .1. IMPROVEMENT OF KINETIC-MODELS [J].
FILSER, JG ;
BOLT, HM .
ARCHIVES OF TOXICOLOGY, 1981, 47 (04) :279-292
[9]  
FILSER JG, 1979, ARCH TOXICOL, V42, P123
[10]  
FISEROVABERGERO.V, 1983, MODELING INHALATION, V1, pCH1